|
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Capitalization1 |
5 023 | 6 518 | 41 340 | 64 799 | - | - |
| Entreprise Value (EV)1 |
4 398 | 5 548 | 36 842 | 53 149 | 43 610 | 39 111 |
| P/E ratio |
-12,5x | -12,6x | -53,3x | 6,54x | 9,11x | 27,6x |
| Yield |
- | - | - | - | - | - |
| Capitalization / Revenue |
37,2x | 108x | 51,5x | 3,53x | 4,15x | 7,63x |
| EV / Revenue |
32,6x | 92,1x | 45,9x | 2,89x | 2,79x | 4,61x |
| EV / EBITDA |
-11,3x | -10,8x | -50,3x | 3,93x | 4,34x | 8,52x |
| Price to Book |
- | 6,14x | 16,3x | 4,53x | 3,06x | 2,42x |
| Nbr of stocks (in thousands) |
328 948 | 333 250 | 395 710 | 401 528 | - | - |
| Reference price (USD) |
15,3 | 19,6 | 104 | 161 | 161 | 161 |
| Last update |
03/06/2019 | 02/26/2020 | 02/25/2021 | 05/07/2021 | 05/07/2021 | 05/07/2021 |
|
1 USD in Million Estimates
|
|
| Income Statement Evolution | |
|
|
|
| Annual Income Statement Data |
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net sales1 |
135 | 60,2 | 803 | 18 363 | 15 626 | 8 489 |
| EBITDA1 |
-388 | -515 | -732 | 13 532 | 10 051 | 4 593 |
| Operating profit (EBIT)1 |
-413 | -546 | -763 | 12 305 | 9 201 | 3 572 |
| Operating Margin |
-306% | -906% | -95,0% | 67,0% | 58,9% | 42,1% |
| Pre-Tax Profit (EBT)1 |
-384 | -515 | -745 | 11 731 | 10 006 | 3 037 |
| Net income1 |
-402 | -514 | -747 | 10 203 | 7 587 | 2 286 |
| Net margin |
-298% | -854% | -93,0% | 55,6% | 48,6% | 26,9% |
| EPS2 |
-1,22 | -1,55 | -1,96 | 24,7 | 17,7 | 5,85 |
| Dividend per Share2 |
- | - | - | - | - | - |
| Last update |
03/06/2019 | 02/26/2020 | 02/25/2021 | 05/12/2021 | 05/12/2021 | 05/12/2021 |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Net Debt1 |
- | - | - | - | - | - |
| Net Cash position1 |
625 | 971 | 4 498 | 11 650 | 21 189 | 25 687 |
| Leverage (Debt / EBITDA) |
1,61x | 1,89x | 6,15x | -0,86x | -2,11x | -5,59x |
| Free Cash Flow1 |
-437 | -491 | 1 960 | 8 826 | 5 876 | 3 160 |
| ROE (Net Profit / Equities) |
-39,3% | -38,0% | -40,0% | 123% | 45,2% | 13,6% |
| Shareholders' equity1 |
1 023 | 1 353 | 1 868 | 8 266 | 16 796 | 16 793 |
| ROA (Net Profit / Asset) |
-25,3% | -28,9% | -16,7% | 84,3% | 42,4% | 4,90% |
| Assets1 |
1 591 | 1 776 | 4 463 | 12 105 | 17 898 | 46 698 |
| Book Value Per Share2 |
- | 3,19 | 6,42 | 35,6 | 52,8 | 66,8 |
| Cash Flow per Share2 |
-1,01 | - | 5,32 | 20,8 | 24,0 | -1,17 |
| Capex1 |
106 | 31,6 | 67,4 | 379 | 252 | 213 |
| Capex / Sales |
78,3% | 52,4% | 8,40% | 2,06% | 1,61% | 2,51% |
| Last update |
03/06/2019 | 02/26/2020 | 02/25/2021 | 05/12/2021 | 05/12/2021 | 05/07/2021 |
|
1 USD in Million 2 USD Estimates
|
|
|
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
Takeda says it may double imports of Moderna shots to help accelerate Japan vaccination |
Capitalization (USD) 64 798 554 588 Net sales (USD) 803 395 000 Sales / Employee (USD) 617 996 Free-Float capitalization (USD) 58 513 101 496 Avg. Exchange 20 sessions (USD) 2 093 754 122 Average Daily Capital Traded 3,23%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
